Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026, is enclosed.
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Agarwal's Health Care has submitted a routine compliance certificate under SEBI's Regulation 74(5) to BSE and NSE. The certificate, issued by KFin Technologies (the company's Registrar and Share Transfer Agent), confirms that details of all shares dematerialized and rematerialized during the January–March 2026 quarter have been duly reported to both CDSL and NSDL depositories as well as the stock exchanges. The filing was signed by the Company Secretary on April 6, 2026. There are no financial figures, share counts, or transaction details disclosed in this submission.
This is a standard quarterly procedural filing with no direct impact on shareholders, operations, or stock price. It simply confirms that the company is meeting its routine compliance obligations regarding share dematerialization reporting.